Isochondodendrine (Bisbenzylisoquinoline · Neuromuscular · Curare Reference)

Compound	Isochondodendrine (Isochondodendrine; Curine; Chondrodendron BBIQ)
Class	Alkaloid — Bisbenzylisoquinoline (BBIQ)
CAS	6871-44-9
Molecular formula	C₃₆H₃₈N₂O₆
Primary sources	Chondrodendron tomentosum (curare vine), Abuta spp.
Plant part	Bark, root bark
Claim strength	Emerging
Key applications	Neuromuscular relaxant reference; historical pharmacology; curare alkaloid series; informational-only
Buy from Herbuno	Informational reference — see HerbIQ Compound Index →

Name origin: Isochondodendrine is named after Chondrodendron tomentosum — the primary botanical source of tubocurarine (the classical curare neuromuscular blocker). The "iso-" prefix denotes its stereochemical relationship to chondodendrine, the epimer at the C-1 position. Traditional use: Chondrodendron tomentosum is the primary source plant for curare — the traditional Amazonian arrow poison used by indigenous hunters for immobilising prey and enemies. Curare preparations (pot curare, tube curare, calabash curare) are complex plant mixtures; C. tomentosum bark is the primary ingredient of tube curare (stored in bamboo tubes). The isolation of tubocurarine from curare by King in 1935 and its pharmaceutical development as a surgical muscle relaxant (intocostrin, d-tubocurarine) transformed anaesthesiology. Isochondodendrine is a minor curare alkaloid with weaker neuromuscular activity than tubocurarine. Research trajectory: Isochondodendrine has been characterised pharmacologically in historical BBIQ research series but has not been developed pharmaceutically — tubocurarine and synthetic successors have dominated neuromuscular blocker development. Safety context: As a neuromuscular blocker, isochondodendrine causes respiratory paralysis at sufficient doses. Not a supplement or nutraceutical compound.

---

Pharmacological Profile of Isochondodendrine

Neuromuscular relaxant activity: Isochondodendrine produces dose-dependent neuromuscular blockade in animal preparations by competitive antagonism at nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction. Its potency is substantially lower than tubocurarine — estimated 5–20-fold less active — due to differences in quaternary nitrogen configuration and overall molecular geometry affecting nAChR active site complementarity. Claim strength: Emerging.

Mechanism comparison with tubocurarine: Tubocurarine is a bis-quaternary ammonium BBIQ — both nitrogen atoms are permanently quaternised, giving it high receptor affinity, very low CNS penetrance, and long duration of action. Isochondodendrine has tertiary amine groups (not permanently quaternised), reducing receptor affinity but allowing limited CNS penetration. This structural difference explains the pharmacological potency hierarchy within the Chondrodendron alkaloid series. Claim strength: Moderate (pharmacological).

Historical pharmacological significance: The isolation and pharmacological characterisation of the Chondrodendron BBIQ alkaloids (tubocurarine, chondocurine, isochondodendrine) in the 1930s–1950s established the structure-activity relationships for neuromuscular blocking drugs, informing the design of all subsequent synthetic NMBAs (pancuronium, vecuronium, rocuronium, atracurium). This work represents one of the most important contributions of natural product pharmacology to clinical medicine. Claim strength: High (historical pharmacology).

---

Frequently Asked Questions — Isochondodendrine

What is curare and what is its relationship to isochondodendrine?
Curare is a generic term for Amazonian arrow poisons made from various plant combinations. Tube curare (the pharmacologically most studied type) is primarily from Chondrodendron tomentosum bark; the active constituents are bisbenzylisoquinoline alkaloids — primarily tubocurarine with isochondodendrine, chondocurine, and others as minor contributors. Isochondodendrine is one of multiple BBIQs in the full Chondrodendron alkaloid extract that collectively produce curare's neuromuscular paralytic effect.

How did curare lead to modern anaesthesia?
Before curare alkaloids were introduced to anaesthesia (1942, Griffith and Johnson, Montreal), surgical muscle relaxation required dangerously deep general anaesthesia. d-Tubocurarine allowed surgeons to achieve adequate muscle relaxation at lighter planes of anaesthesia, revolutionising abdominal and thoracic surgery. The development of all modern NMBAs (succinylcholine, pancuronium, vecuronium, rocuronium, cisatracurium) traces directly to the SAR studies conducted on tubocurarine and the Chondrodendron alkaloid series including isochondodendrine.

Why does curare not cause poisoning when eating animals killed with curare arrows?
Tubocurarine and related BBIQs are quaternary or pseudo-quaternary ammonium compounds — they are not absorbed from the gastrointestinal tract in significant quantities. Oral curare ingestion produces minimal systemic toxicity because the alkaloids cannot cross the GI mucosa; the toxin only enters systemic circulation directly (via the bloodstream from arrow wounds). This is the basis for the historical Amazon practice of eating curare-killed game without risk.

Is isochondodendrine found in any currently used pharmaceutical preparations?
No. d-Tubocurarine (the purified principal Chondrodendron alkaloid) was used clinically until the 1980s when synthetic NMBAs with better safety profiles replaced it. Isochondodendrine has never been pharmaceutically developed. All current clinical NMBAs are synthetic or semi-synthetic compounds inspired by the tubocurarine SAR template.

Related compounds: Chondrocurarine, Thalidasine, Tetrandrine, Cissampareine

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery